Elixir Medical Co-Founder and Chief Technical Officer John Yan describes how the unique uncaging elements of the DynamX™ Coronary Bioadaptor System work to enhance vessel needs and potentially improve patient outcomes.
Read about Dr. Stefan Verheye’s experience studying the bioadaptor and its potential to improve patient outcomes.
Some of the most significant innovations in treating heart disease over the last half century have been focused on CAD.
The Associate Director/Director Clinical Scientist provides scientific expertise throughout the development and implementation of clinical evaluations, risk management and /or clinical studies.
The Associate Director/Director Clinical Scientist provides scientific expertise throughout the development and implementation of clinical evaluations, risk management and /or clinical studies.
